Rhesus Negative Obstetric Population in Western Australia Receiving Treatment for the Prevention of Sensitisation to the D-Antigen: Comparison of Existing Australian Dosing Regime and a Single 1500IU Dose to Assess Protection from Sensitisation and Patient Compliance
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Anti-D Rh0 immunoglobulin (Primary)
- Indications Haemolytic disease of newborn; Pregnancy complications
- Focus Therapeutic Use
- Acronyms DACTR
- 20 Apr 2017 Status changed from recruiting to completed.
- 26 Aug 2013 New trial record